In addition, the Vps34 inhibitor, Vps34-IN1, increased cytotoxic activity in MCF-7 and MDA-MB-231 cells when treated with sunitinib and erlotinib, which have shown modest activity in patients with BC [47,48]. The gene discussed is PIK3C3; the disease is breast cancer.